Browsing by Contributors Rader, Daniel J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 10 of 10
PreviewIssue DateTitleContributor(s)
2017 AJCN Volume 106 Issue 4 October (2).pdf.jpg2017Can changes in the plasma lipidome help explain the cardiovascular benefits of the Mediterranean diet ?Bajaj, Archna; Rader, Daniel J
2017 AJC Volume 119 Issue 6 March (12).pdf.jpg2017Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective CohortEmdin, Connor A; Khera, Amit V; Natarajan, Pradeep; Klarin, Derek; Baber, Usman; Mehran, Roxana; Rader, Daniel J; Fuster, Valentin; Kathiresan, Sekar
2017 JACC Volume 69 Issue 6 February (9).pdf.jpg2017Intracoronary Imaging, Reverse Cholesterol Transport, and TranscriptomicsChhatriwalla, Adnan K; Rader, Daniel J
1071.pdf.jpg10-Sep-2015Lysosomal Acid Lipase Deficiency--A New Therapy for a Genetic Lipid DiseaseRader, Daniel J
2017 CIR Volume 135 Issue 7 February (4).pdf.jpg2017Mediterranean Approach to Improving High-Density Lipoprotein Function.Rader, Daniel J
694.pdf.jpg1-Sep-2015On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study)Khera, Amit V; Qamar, Arman; Murphy, Sabina A; Cannon, Christopher P; Sabatine, Marc S; Rader, Daniel J
3020.full.pdf.jpg14-Nov-2015Potent peroxisome proliferator-activated receptor-α agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndromeKhera, Amit V; Millar, John S; Ruotolo, Giacomo; Wang, Ming-Dauh; Rader, Daniel J
2014Residual macrovascular risk in 2013: what have we learned?Fruchart, Jean-Charles; Davignon, Jean; Hermans, Michel P; Al-Rubeaan, Khalid; Amarenco, Pierre; Assmann, Gerd; Barter, Philip; Betteridge, John; Bruckert, Eric; Cuevas, Ada; Farnier, Michel; Ferrannini, Ele; Fioretto, Paola; Genest, Jacques; Ginsberg, Henry N; Gotto, Antonio M; Hu, Dayi; Kadowaki, Takashi; Kodama, Tatsuhiko; Krempf, Michel; Matsuzawa, Yuji; Núñez-Cortés, Jesús Millán; Monfil, Carlos Calvo; Ogawa, Hisao; Plutzky, Jorge; Rader, Daniel J; Sadikot, Shaukat; Santos, Raul D; Shlyakhto, Evgeny; Sritara, Piyamitr; Sy, Rody; Tall, Alan; Tan, Chee Eng; Tokgözoğlu, Lale; Toth, Peter P; Valensi, Paul; Wanner, Christoph; Zambon, Alberto; Zhu, Junren; Zimmet, Paul
266.pdf.jpgAug-2015Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyShah, Rachana; Matthews, Gregory J; Shah, Rhia Y; McLaughlin, Catherine; Chen, Jing; Wolman, Melanie; Master, Stephen R; Chai, Boyang; Xie, Dawei; Rader, Daniel J; Raj, Dominic S; Mehta, Nehal N; Budoff, Matthew; Fischer, Michael J; Go, Alan S; Townsend, Raymond R; He, Jiang; Kusek, John W; Feldman, Harold I; Foulkes, Andrea S; Reilly, Muredach P
2016 EHJ Volume 37 Issue 17 April (5).pdf.jpg2016Vascular medicine Safety and efficacy of LY3015014 , a monoclonal antibody to proprotein convertase subtilisin / kexin type 9 ( PCSK9 ): a randomized , placebo-controlled Phase 2 studyKastelein, John J P; Nissen, Steven E; Rader, Daniel J; Hovingh, G Kees; Wang, Ming-dauh; Shen, Tong; Krueger, Kathryn A